Common use of Formation and Composition Clause in Contracts

Formation and Composition. Within [***] days of the Effective Date, the Parties will establish the Joint Development Committee composed [***] appointed [***] of each of Licensee and Mersana. A Party may change [***] on the Joint Development Committee at any time or elect to have one (1) of its members represented by a delegate at a meeting of the Joint Development Committee, subject to the confidentiality provisions of Article 10. [***]. The chairperson shall not have any greater authority than any other representative on the Joint Development Committee and shall be responsible for the following activities of the Joint Development Committee: (a) calling meetings of the Joint Development Committee, (b) preparing and issuing minutes of each such meeting within [***] days thereafter, which minutes shall not be finalized until each Party reviews and confirms the accuracy of such minutes in writing (provided that any minutes shall be deemed approved unless a Party’s representative to the committee objects to the accuracy of such minutes within [***] days of the circulation of the minutes by the committee), and (c) preparing and circulating an agenda for the upcoming meeting; provided, that the chairperson shall include any agenda items proposed by the Party of which the chairperson is not a representative. The Parties may allow additional employees to attend meetings of the Joint Development Committee subject to the confidentiality [***] Portions of this exhibit have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. provisions of Article 10. Joint Development Committee members shall have sufficient expertise and sufficient seniority and authority with respect to the applicable Party to make decisions within the scope of the Joint Development Committee’s authority, including with respect to clinical, regulatory and business matters relating to Development.

Appears in 2 contracts

Samples: Commercial License Agreement (Mersana Therapeutics, Inc.), Commercial License Agreement (Mersana Therapeutics, Inc.)

AutoNDA by SimpleDocs

Formation and Composition. Within [***] days of On the Effective Date, the Parties will shall establish the Joint Development Manufacturing Committee composed of [***] appointed [***] of each of Licensee and Mersana. A Party may change [***] on the Joint Development Manufacturing Committee at any time or elect to have one (1) of its members member represented by a delegate at a meeting of the Joint Development Manufacturing Committee, subject to the confidentiality provisions of Article 10. [***]. The chairperson shall not have any greater authority than any the other representative on the Joint Development Manufacturing Committee and shall be responsible for the following activities of the Joint Development Manufacturing Committee: (ai) calling meetings of the Joint Development Manufacturing Committee, (bii) preparing and issuing minutes of each such meeting within [***] days thereafter, which minutes shall not be finalized until each Party reviews and confirms the accuracy of such minutes in writing (provided that any minutes shall be deemed approved unless a Party’s representative to the committee objects to the accuracy of such minutes within [***] days of the circulation of the minutes by the committee), and (ciii) preparing and circulating an agenda for the upcoming meeting; provided, that the chairperson shall include any agenda items proposed by the Party of which the chairperson is not a representative. The Parties may allow additional employees or consultants to attend meetings of the Joint Development Manufacturing Committee subject to the confidentiality provisions of Article 10. Joint Manufacturing Committee members shall have sufficient expertise and sufficient seniority with respect to the applicable Party to make decisions [***] Portions of this exhibit have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. provisions of Article 10. Joint Development Committee members shall have sufficient expertise and sufficient seniority and authority with respect to the applicable Party to make decisions within the scope of the Joint Development Manufacturing Committee’s authority, including with respect to clinical, regulatory and business matters relating to Developmentmanufacture.

Appears in 2 contracts

Samples: Commercial License Agreement (Mersana Therapeutics, Inc.), Commercial License Agreement (Mersana Therapeutics, Inc.)

AutoNDA by SimpleDocs

Formation and Composition. Within Promptly following Initiation of the [***] days of Clinical Trial under the Effective DateGlobal Development Plan, or earlier as needed, the Parties will shall establish the a joint commercialization committee (“Joint Development Committee Commercialization Committee”) composed of [***] appointed [***] of each of Licensee and Mersana. A Party may change [***] on the Joint Development Commercialization Committee at any time or elect to have one (1) of its members [***] Portions of this exhibit have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. represented by a delegate at a meeting of the Joint Development Commercialization Committee, subject to the confidentiality provisions of Article 10. [***]. The chairperson shall not have any greater authority than any other representative on the Joint Development Commercialization Committee and shall be responsible for the following activities of the Joint Development Commercialization Committee: (ai) calling meetings of the Joint Development Commercialization Committee, (bii) preparing and issuing minutes of each such meeting within [***] days thereafter, which minutes shall not be finalized until each Party reviews and confirms the accuracy of such minutes in writing (provided that any minutes shall be deemed approved unless a Party’s representative to the committee objects to the accuracy of such minutes within [***] days of the circulation of the minutes by the committee), and (ciii) preparing and circulating an agenda for the upcoming meeting; provided, that the chairperson shall include any agenda items proposed by the Party of which the chairperson is not a representative. The Parties may allow additional employees or consultants to attend meetings of the Joint Development Commercialization Committee subject to the confidentiality [***] Portions of this exhibit have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. provisions of Article 10. Joint Development Commercialization Committee members shall have sufficient expertise and sufficient seniority and authority with respect to the applicable Party to make decisions within the scope of the Joint Development Commercialization Committee’s authority, including with respect to clinical, regulatory and business matters relating to Development.

Appears in 2 contracts

Samples: Commercial License Agreement (Mersana Therapeutics, Inc.), Commercial License Agreement (Mersana Therapeutics, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!